Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.33), $0.15 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.